BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1021 related articles for article (PubMed ID: 27287253)

  • 1. Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin.
    Balogh E; Tolnai E; Nagy B; Nagy B; Balla G; Balla J; Jeney V
    Biochim Biophys Acta; 2016 Sep; 1862(9):1640-9. PubMed ID: 27287253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
    Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
    Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
    Zhong S; He X; Li Y; Lou X
    Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line.
    Su SJ; Chang KL; Su SH; Yeh YT; Shyu HW; Chen KM
    Int J Food Sci Nutr; 2013 Jun; 64(4):429-36. PubMed ID: 23301724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
    Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
    Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-155 inhibits the osteogenic differentiation of mesenchymal stem cells induced by BMP9 via downregulation of BMP signaling pathway.
    Liu H; Zhong L; Yuan T; Chen S; Zhou Y; An L; Guo Y; Fan M; Li Y; Sun Y; Li W; Shi Q; Weng Y
    Int J Mol Med; 2018 Jun; 41(6):3379-3393. PubMed ID: 29512689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells.
    Chen XH; Shi ZG; Lin HB; Wu F; Zheng F; Wu CF; Huang MW
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6352-6359. PubMed ID: 31364143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis.
    Yu L; Xu Y; Qu H; Yu Y; Li W; Zhao Y; Qiu G
    J Cell Physiol; 2019 Apr; 234(4):4314-4326. PubMed ID: 30132874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pax2 is essential for proliferation and osteogenic differentiation of mouse mesenchymal stem cells via Runx2.
    Lu M; Guo S; Hong F; Zhang Y; Yuan L; Ma C; Ma J
    Exp Cell Res; 2018 Oct; 371(2):342-352. PubMed ID: 30144446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of zinc fingers and homeoboxes 3 on the regulation of mesenchymal stem cell osteogenic differentiation.
    Suehiro F; Nishimura M; Kawamoto T; Kanawa M; Yoshizawa Y; Murata H; Kato Y
    Stem Cells Dev; 2011 Sep; 20(9):1539-47. PubMed ID: 21174497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferritin ferroxidase activity: a potent inhibitor of osteogenesis.
    Zarjou A; Jeney V; Arosio P; Poli M; Zavaczki E; Balla G; Balla J
    J Bone Miner Res; 2010 Jan; 25(1):164-72. PubMed ID: 19821764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells.
    Shih YR; Tseng KF; Lai HY; Lin CH; Lee OK
    J Bone Miner Res; 2011 Apr; 26(4):730-8. PubMed ID: 20939067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells.
    Müller B; Prante C; Gastens M; Kuhn J; Kleesiek K; Götting C
    Matrix Biol; 2008 Mar; 27(2):139-49. PubMed ID: 17980567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑217 inhibits osteogenic differentiation of rat bone marrow‑derived mesenchymal stem cells by binding to Runx2.
    Zhu YL; Wang S; Ding DG; Xu L; Zhu HT
    Mol Med Rep; 2017 May; 15(5):3271-3277. PubMed ID: 28339007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [REGUL ATORY EFFECT OF SIMVASTATIN ON MIDDLE/L ATE STAGES OSTEOGENIC DIFFERENTIATION OF BONE MARROW MESENCHYMAL STEM CELLS VIA p38MAPK PATHWAY].
    Zhang K; Liu G; Tian F; Zhang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Aug; 30(8):1038-1043. PubMed ID: 29786238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Dlx2 enhances osteogenic differentiation of BMSCs and MC3T3-E1 cells via direct upregulation of Osteocalcin and Alp.
    Zhang J; Zhang W; Dai J; Wang X; Shen SG
    Int J Oral Sci; 2019 Mar; 11(2):12. PubMed ID: 30880332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mir-150-5p inhibits the osteogenic differentiation of bone marrow-derived mesenchymal stem cells by targeting irisin to regulate the p38/MAPK signaling pathway.
    Qi JL; Zhang ZD; Dong Z; Shan T; Yin ZS
    J Orthop Surg Res; 2024 Mar; 19(1):190. PubMed ID: 38500202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel tissue-engineered bone constructed by using human adipose-derived stem cells and biomimetic calcium phosphate scaffold coprecipitated with bone morphogenetic protein-2].
    Jiang WR; Zhang X; Liu YS; Wu G; Ge YJ; Zhou YS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 49(1):6-15. PubMed ID: 28202997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-23b targets Smad 3 and ameliorates the LPS-inhibited osteogenic differentiation in preosteoblast MC3T3-E1 cells.
    Liu H; Hao W; Wang X; Su H
    J Toxicol Sci; 2016 Apr; 41(2):185-93. PubMed ID: 26961602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.